BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 15369199)

  • 1. MDMA/Ecstasy use among young people in Ohio: perceived risk and barriers to intervention.
    Carlson RG; Falck RS; McCaughan JA; Siegal HA
    J Psychoactive Drugs; 2004 Jun; 36(2):181-9. PubMed ID: 15369199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sources of information about MDMA (3,4-methylenedioxymethamphetamine): perceived accuracy, importance, and implications for prevention among young adult users.
    Falck RS; Carlson RG; Wang J; Siegal HA
    Drug Alcohol Depend; 2004 Apr; 74(1):45-54. PubMed ID: 15072806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From ecstasy to MDMA: Recreational drug use, symbolic boundaries, and drug trends.
    Edland-Gryt M; Sandberg S; Pedersen W
    Int J Drug Policy; 2017 Dec; 50():1-8. PubMed ID: 28869878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. It's a rave new world: estimating the prevalence and perceived harm of ecstasy and other drug use among club rave attendees.
    Yacoubian GS; Boyle C; Harding CA; Loftus EA
    J Drug Educ; 2003; 33(2):187-96. PubMed ID: 12929709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preventing problems in Ecstasy users: reduce use to reduce harm.
    Baggott MJ
    J Psychoactive Drugs; 2002; 34(2):145-62. PubMed ID: 12691205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From "Candy Kids" to "Chemi-Kids": a typology of young adults who attend raves in the midwestern United States.
    McCaughan JA; Carlson RG; Falck RS; Siegal HA
    Subst Use Misuse; 2005; 40(9-10):1503-23. PubMed ID: 16048830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is ecstasy perceived to be safe? A critical survey.
    Gamma A; Jerome L; Liechti ME; Sumnall HR
    Drug Alcohol Depend; 2005 Feb; 77(2):185-93. PubMed ID: 15664720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shifting characteristics of ecstasy users ages 12-34 in the United States, 2007-2014.
    Palamar JJ; Mauro PM; Han BH; Martins SS
    Drug Alcohol Depend; 2017 Dec; 181():20-24. PubMed ID: 29028555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: how strong is the evidence for persistent brain damage?
    Gouzoulis-Mayfrank E; Daumann J
    Addiction; 2006 Mar; 101(3):348-61. PubMed ID: 16499508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High incidence of mild hyponatraemia in females using ecstasy at a rave party.
    van Dijken GD; Blom RE; Hené RJ; Boer WH; NIGRAM Consortium
    Nephrol Dial Transplant; 2013 Sep; 28(9):2277-83. PubMed ID: 23476039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
    Thomasius R; Zapletalova P; Petersen K; Buchert R; Andresen B; Wartberg L; Nebeling B; Schmoldt A
    J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Memory performance in polyvalent MDMA (ecstasy) users who continue or discontinue MDMA use.
    Gouzoulis-Mayfrank E; Fischermann T; Rezk M; Thimm B; Hensen G; Daumann J
    Drug Alcohol Depend; 2005 Jun; 78(3):317-23. PubMed ID: 15893163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Careers in ecstasy use: do ecstasy users cease of their own accord? Implications for intervention development.
    Peters GJ; Kok G; Schaalma HP
    BMC Public Health; 2008 Oct; 8():376. PubMed ID: 18957117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug use practices among MDMA/ecstasy users in Ohio: a latent class analysis.
    Carlson RG; Wang J; Falck RS; Siegal HA
    Drug Alcohol Depend; 2005 Aug; 79(2):167-79. PubMed ID: 16002026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impulsivity, risk taking and recreational 'ecstasy' (MDMA) use.
    Butler GK; Montgomery AM
    Drug Alcohol Depend; 2004 Oct; 76(1):55-62. PubMed ID: 15380289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk and benefit perceptions of party drug use.
    White B; Degenhardt L; Breen C; Bruno R; Newman J; Proudfoot P
    Addict Behav; 2006 Jan; 31(1):137-42. PubMed ID: 15907371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case of acute psychotic episode after a single dose of ecstasy].
    Vaiva G; Bailly D; Boss V; Thomas P; Lestavel P; Goudemand M
    Encephale; 2001; 27(2):198-202. PubMed ID: 11407274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Young adults' recreational social environment as a predictor of ecstasy use initiation: findings of a population-based prospective study.
    Smirnov A; Najman JM; Hayatbakhsh R; Wells H; Legosz M; Kemp R
    Addiction; 2013 Oct; 108(10):1809-17. PubMed ID: 23668641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alcohol use and risk taking among regular ecstasy users.
    Breen C; Degenhardt L; Kinner S; Bruno R; Jenkinson R; Matthews A; Newman J
    Subst Use Misuse; 2006; 41(8):1095-109. PubMed ID: 16798678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attributions for psychobiological changes in ecstasy/MDMA and other polydrug users.
    Soar K; Parrott A; Turner J
    J Psychopharmacol; 2009 Sep; 23(7):745-58. PubMed ID: 18635698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.